Literature DB >> 26739556

Are itch and scratching the nausea and vomiting of skin?

Sattar Ostadhadi1,2,3, Ehsan Azimi4, Ethan A Lerner4, Ahmad-Reza Dehpour1,2,3.   

Abstract

The physiologic similarities between itch and nausea may not be evident initially, but they share the role of repelling irritants and toxins from the body by inducting scratching and vomiting, respectively. In addition, itch and nausea frequently occur together in certain conditions such as uraemia. Here we show that the mechanisms underlying itch and nausea overlap and that advances in either field may influence the identification of novel drug targets, particularly for itch.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  itch; nausea; scratching; vomiting

Mesh:

Year:  2016        PMID: 26739556      PMCID: PMC5445905          DOI: 10.1111/exd.12935

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  89 in total

1.  Vascular reactions of the skin to injury: Part VIII. The resistance of the human skin to constant currents, in relation to injury and vascular response.

Authors:  T Lewis; Y Zotterman
Journal:  J Physiol       Date:  1927-01-12       Impact factor: 5.182

2.  A controlled trial of ondansetron in the pruritus of cholestasis.

Authors:  J W O'Donohue; S P Pereira; A C Ashdown; C G Haigh; J R Wilkinson; R Williams
Journal:  Aliment Pharmacol Ther       Date:  2005-04-15       Impact factor: 8.171

3.  Substance P induces degranulation of mast cells and leukocyte adhesion to venular endothelium.

Authors:  H Suzuki; S Miura; Y Y Liu; M Tsuchiya; H Ishii
Journal:  Peptides       Date:  1995       Impact factor: 3.750

4.  Cutaneous manifestations of the malignant carcinoid syndrome.

Authors:  H K Bell; G J Poston; J Vora; N J E Wilson
Journal:  Br J Dermatol       Date:  2005-01       Impact factor: 9.302

5.  Treatment of pruritus with topically applied opiate receptor antagonist.

Authors:  Paul L Bigliardi; Holger Stammer; Gerhard Jost; Theo Rufli; Stanislaw Büchner; Mei Bigliardi-Qi
Journal:  J Am Acad Dermatol       Date:  2007-02-22       Impact factor: 11.527

6.  Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.

Authors:  Zbigniew Zylicz; Malgorzata Krajnik; Adriaan Alistar van Sorge; Massimo Costantini
Journal:  J Pain Symptom Manage       Date:  2003-12       Impact factor: 3.612

7.  Possible roles of epidermal opioid systems in pruritus of atopic dermatitis.

Authors:  Mitsutoshi Tominaga; Hideoki Ogawa; Kenji Takamori
Journal:  J Invest Dermatol       Date:  2007-07-05       Impact factor: 8.551

8.  Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

Authors:  Sonja Ständer; Barbara Böckenholt; Funda Schürmeyer-Horst; Carsten Weishaupt; Gereon Heuft; Thomas A Luger; Gudrun Schneider
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

Review 9.  Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV).

Authors:  Rudolph M Navari
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

10.  Molecular signaling and targets from itch: lessons for cough.

Authors:  Pamela Colleen Lavinka; Xingzhong Dong
Journal:  Cough       Date:  2013-03-06
View more
  2 in total

Review 1.  Physiology and Pathophysiology of Itch.

Authors:  Ferda Cevikbas; Ethan A Lerner
Journal:  Physiol Rev       Date:  2019-12-23       Impact factor: 37.312

2.  The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).

Authors:  Longlong Tu; Zengbing Lu; Man P Ngan; Francis F Y Lam; Claudio Giuliano; Emanuela Lovati; Claudio Pietra; John A Rudd
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.